Arcadia Biosciences (RKDA) Stock Price Up -0.2%
Arcadia Biosciences Inc (NASDAQ:RKDA) shares rose 0.2% during trading on Thursday . The stock traded as high as $5.76 and last traded at $5.27. Approximately 1,200 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 412,485 shares. The stock had previously closed at $5.28.
Several research analysts recently weighed in on the company. HC Wainwright set a $20.00 target price on Arcadia Biosciences and gave the stock a “buy” rating in a research note on Thursday, July 19th. Zacks Investment Research upgraded Arcadia Biosciences from a “sell” rating to a “hold” rating in a research note on Wednesday. Finally, ValuEngine upgraded Arcadia Biosciences from a “sell” rating to a “hold” rating in a research note on Tuesday, October 2nd.
The company has a market capitalization of $23.34 million, a price-to-earnings ratio of -0.72 and a beta of -5.58.
An institutional investor recently bought a new position in Arcadia Biosciences stock. Ardsley Advisory Partners bought a new position in shares of Arcadia Biosciences Inc (NASDAQ:RKDA) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 25,000 shares of the basic materials company’s stock, valued at approximately $206,000. Ardsley Advisory Partners owned about 1.01% of Arcadia Biosciences at the end of the most recent reporting period. 8.10% of the stock is currently owned by institutional investors.
Arcadia Biosciences Company Profile (NASDAQ:RKDA)
Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.
Recommended Story: Determine Your Level of Risk Tolerance
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.